Copy number variation of glyoxalase I
- PMID: 24646268
- DOI: 10.1042/BST20140011
Copy number variation of glyoxalase I
Abstract
The glyoxalase I gene GLO1 is a hotspot for copy number variation in the human and mouse genomes. The additional copies are often functional, giving rise to 2-4-fold increased glyoxalase I expression and activity. The prevalence of GLO1 copy number increase in the human population appears to be approximately 2% and may be linked to a risk of obesity, diabetes and aging. Increased GLO1 copy number has been found in human tumour cell lines and primary human tumours. The minimum common copy number increase region was approximately 1 Mb and it contained GLO1 and seven other genes. The increased copy number was generally functional, being associated with increased glyoxalase I protein and multidrug resistance in cancer chemotherapy. Glo1 duplication in the mouse genome is found within approximately 0.5 Mb of duplicated DNA. It was claimed to be linked to anxiety phenotypes, but other related discordant findings have doubted the association with glyoxalase I and further investigation is required.
Similar articles
-
Activity, regulation, copy number and function in the glyoxalase system.Biochem Soc Trans. 2014 Apr;42(2):419-24. doi: 10.1042/BST20140008. Biochem Soc Trans. 2014. PMID: 24646254 Review.
-
Gene doubling increases glyoxalase 1 expression in RAGE knockout mice.Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129438. doi: 10.1016/j.bbagen.2019.129438. Epub 2019 Sep 14. Biochim Biophys Acta Gen Subj. 2020. PMID: 31526867
-
A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior.PLoS One. 2009;4(3):e4649. doi: 10.1371/journal.pone.0004649. Epub 2009 Mar 6. PLoS One. 2009. PMID: 19266052 Free PMC article.
-
Reappraisal of putative glyoxalase 1-deficient mouse and dicarbonyl stress on embryonic stem cells in vitro.Biochem J. 2016 Nov 15;473(22):4255-4270. doi: 10.1042/BCJ20160691. Epub 2016 Sep 26. Biochem J. 2016. PMID: 27671893
-
Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy.Semin Cancer Biol. 2018 Apr;49:83-93. doi: 10.1016/j.semcancer.2017.05.006. Epub 2017 May 12. Semin Cancer Biol. 2018. PMID: 28506645 Review.
Cited by
-
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.Glycoconj J. 2016 Aug;33(4):513-25. doi: 10.1007/s10719-016-9705-z. Epub 2016 Jul 12. Glycoconj J. 2016. PMID: 27406712 Free PMC article. Review.
-
Exosomal MALAT1 promotes the proliferation of esophageal squamous cell carcinoma through glyoxalase 1-dependent methylglyoxal removal.Noncoding RNA Res. 2024 Jan 10;9(2):330-340. doi: 10.1016/j.ncrna.2024.01.003. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38505306 Free PMC article.
-
Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).Oncotarget. 2017 Aug 16;8(44):76961-76973. doi: 10.18632/oncotarget.20290. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100361 Free PMC article.
-
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.Int J Mol Sci. 2022 Feb 23;23(5):2453. doi: 10.3390/ijms23052453. Int J Mol Sci. 2022. PMID: 35269594 Free PMC article. Review.
-
The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).Int J Mol Sci. 2017 Nov 20;18(11):2466. doi: 10.3390/ijms18112466. Int J Mol Sci. 2017. PMID: 29156655 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous